Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.

Clarke, Robert; Jones, Brandon C; Sevigny, Catherine M; Hilakivi-Clarke, Leena A; Sengupta, Surojeet

Clarke, Robert; Jones, Brandon C; Sevigny, Catherine M; Hilakivi-Clarke, Leena A; Sengupta, Surojeet.

Afiliación

Clarke R; The Hormel Institute and Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Austin, MN 55912, USA.
Jones BC; Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA.
Sevigny CM; Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA.
Hilakivi-Clarke LA; The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
Sengupta S; The Hormel Institute and Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Austin, MN 55912, USA.

Cancer Drug Resist ; 4: 762-783, 2021.

Article en En | MEDLINE | ID: mdl-34532657

Palabras clave

Breast cancer; PDX; experimental models; study design; xenografts

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google